ODC1 and cancer: This in vivo study demonstrates that fucoxanthin 38 inhibits ornithine decarboxylase (ODC) activity [171], an enzyme whose activity is induced in response to cell growth stimuli and is highly expressed in diseases such as inflammation and cancer being not only a biomarker for cancer but also a potential target for its therapy [172].